TY - JOUR
T1 - Extending the boundaries of cancer therapeutic complexity with literature text mining
AU - Niezni, Danna
AU - Taub-Tabib, Hillel
AU - Harris, Yuval
AU - Sason, Hagit
AU - Amrusi, Yakir
AU - Meron-Azagury, Dana
AU - Avrashami, Maytal
AU - Launer-Wachs, Shaked
AU - Borchardt, Jon
AU - Kusold, M.
AU - Tiktinsky, Aryeh
AU - Hope, Tom
AU - Goldberg, Yoav
AU - Shamay, Yosi
N1 - Publisher Copyright:
© 2023 Elsevier B.V.
PY - 2023/11
Y1 - 2023/11
N2 - Drug combination therapy is a main pillar of cancer therapy. As the number of possible drug candidates for combinations grows, the development of optimal high complexity combination therapies (involving 4 or more drugs per treatment) such as RCHOP-I and FOLFIRINOX becomes increasingly challenging due to combinatorial explosion. In this paper, we propose a text mining (TM) based tool and workflow for rapid generation of high complexity combination treatments (HCCT) in order to extend the boundaries of complexity in cancer treatments. Our primary objectives were: (1) Characterize the existing limitations in combination therapy; (2) Develop and introduce the Plan Builder (PB) to utilize existing literature for drug combination effectively; (3) Evaluate PB's potential in accelerating the development of HCCT plans. Our results demonstrate that researchers and experts using PB are able to create HCCT plans at much greater speed and quality compared to conventional methods. By releasing PB, we hope to enable more researchers to engage with HCCT planning and demonstrate its clinical efficacy.
AB - Drug combination therapy is a main pillar of cancer therapy. As the number of possible drug candidates for combinations grows, the development of optimal high complexity combination therapies (involving 4 or more drugs per treatment) such as RCHOP-I and FOLFIRINOX becomes increasingly challenging due to combinatorial explosion. In this paper, we propose a text mining (TM) based tool and workflow for rapid generation of high complexity combination treatments (HCCT) in order to extend the boundaries of complexity in cancer treatments. Our primary objectives were: (1) Characterize the existing limitations in combination therapy; (2) Develop and introduce the Plan Builder (PB) to utilize existing literature for drug combination effectively; (3) Evaluate PB's potential in accelerating the development of HCCT plans. Our results demonstrate that researchers and experts using PB are able to create HCCT plans at much greater speed and quality compared to conventional methods. By releasing PB, we hope to enable more researchers to engage with HCCT planning and demonstrate its clinical efficacy.
KW - Combination therapy
KW - Crowdsourcing
KW - Drug synergy
KW - Literature-based discovery
KW - Personalized therapy
KW - Text mining
UR - http://www.scopus.com/inward/record.url?scp=85174014810&partnerID=8YFLogxK
U2 - 10.1016/j.artmed.2023.102681
DO - 10.1016/j.artmed.2023.102681
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 37925210
AN - SCOPUS:85174014810
SN - 0933-3657
VL - 145
JO - Artificial Intelligence in Medicine
JF - Artificial Intelligence in Medicine
M1 - 102681
ER -